3 ms·
-80C storage requirement may really complicate distribution logistics even in developed countries. We'd really need special locations to be setup to administer
by ineedasername 6y ago
-80C storage requirement may really complicate distribution logistics even in developed countries. We'd really need special locations to be setup to administer the vaccine, unless it's viable for some reasonable period of time at higher temperatures. Even something like 24-48 hours, so it can be transported on demand from centralized locations to doctors offices, pharmacies, etc.
Otherwise, medical cryo storage is highly specialized and expensive equipment. Definitely not what you'd find in a doctors office or pharmacy. It might be a more convenient option if the vaccine remains viable at much colder temperatures. Somewhat cheaper (though still not cheap) LN2 transport containers ~180C could be used to deliver it to locations, provide a supply of LN2 to keep it cold, and then warm on demand.
The point is, this isn't going to be a rollout that can be done without a lot of infrastructure planning way up front. If the data here is validated and it looks like it's going to get FDA approval, we need to begin planning that stage ASAP.